However, a significant increase in the percentage of positive cells was observed in SSc-ILD group for CD163, CD169, CD204, CD64 and CD36 when compared to Neo group and for CD163 and CD169 when compared to Sarco group (Figure 2). Here, SIGLEC1 is linked to systemic sclerosis.